Follow
Albert Torra
Albert Torra
PhD, MBA
Verified email at vhir.org
Title
Cited by
Cited by
Year
Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson’s disease pathogenesis
I Carballo-Carbajal, A Laguna, J Romero-Giménez, T Cuadros, J Bové, ...
Nature Communications 10 (1), 973, 2019
2572019
CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson’s disease
J Galiano-Landeira, A Torra, M Vila, J Bové
Brain, 2020
1342020
Overexpression of TFEB drives a pleiotropic neurotrophic effect and prevents Parkinson’s disease-related neurodegeneration
A Torra, A Parent, T Cuadros, B Rodríguez-Galván, E Ruiz-Bronchal, ...
Molecular Therapy 26 (6), 1552-1567, 2018
722018
Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson’s disease pathogenesis. Nat Commun 2019; 10: 973
I Carballo-Carbajal, A Laguna, J Romero-Giménez, T Cuadros, J Bové, ...
DOI: https://doi. org/10.1038/s41467-019-08858-y. PMID: https://www. ncbi …, 0
7
465 Tirbanibulin, a novel anti-proliferative and pro-apoptotic agent for the treatment of actinic keratosis
L Pitzonka, M Cutler, Y Bu, A Blanco, E Fumero, A Torra, M Smolinski
Journal of Investigative Dermatology 141 (5), S81, 2021
32021
Favorable safety profile of tirbanibulin ointment 1% for actinic keratosis: pooled results from two phase III studies
T Schlesinger, N Bhatia, B Berman, A Grada, A Torra, D Cutler, ...
J of Skin 4 (6), s120, 2020
22020
Transcription factor EB-mediated neurotrophic and neuroprotective effects: relevance to Parkinson's disease
A Torra i Talavera
2019
The system can't perform the operation now. Try again later.
Articles 1–7